|
|
|
Factores psicológicos que intervienen en el desarrollo del cáncer y en la respuesta al tratamiento Psichological factors in the development of cancer and in the response to treatment J.P. Arbizu Servicio de Oncología. Hospital de Navarra. Pamplona |
|
BIBLIOGRAFÍA 1. Bayes R. Psicología y cáncer: prevención. En: Martínez Roca, editor. Psicología Oncológica. Barcelona, 1990: 47-111. 2. González A, Gonzalez MJ, García P. Control del cáncer. En: Noticias de Salud Monográficos: Cáncer, Madrid: Consejería de Salud 1994. 3. House JS, Landis KR, Umberson D. Social relationship and health. Science 1998; 241: 540-545. 4. Bovbjerg D. Psychoneuroinmunology and cancer. En: JC Holland JH Rowland, editor. Handbook of Psychooncology. New York, 1990: 727-734. 5. Kiecolt-Glaser JK, Glaser R. Stress and inmune function. En: Ader R, Felten DL, Cohen N editores. Psychoneuroinmunology. New York, Academic Press, 1991: 849-868. 6. Lexander M, Furst CJ, Rotstein S, Hursti RJ, Fredrikson M. Inmune effects of relaxation during chemotherapy for ovarian cancer. Psychother Psychosom 1997; 66: 185-191. 7. Gruber BL, Hall NR, Hersh SP, Dubois P. Inmune system and psychological changes in metastatic cancer patients using relaxation and guided imagery: a pilot study. Scand Behav Ther 1988; 17: 153-156. 8. Faller H, Bulzebruck H, Drings P, Lang H. Coping, distress, and survival among patients with lung cancer. Arch Gen Psychiatry 1999; 56: 756-762. 9. Sklar LS, Anisman H. Stress and cancer. Psychol Bull 1981; 89: 369-406. 10. Wayner L, Cox T. Mackay C. Stress, inmunity and cancer. En: Oborne M, Gruneberg M. Eiser JR, editores. Res Psychol Med. Londres 1979: 253-259. 11. Morris T, Greer S. A "type C" for cancer?. Cancer Detect Prev 1980; 3: 102. 12. Temoshok L. Personality, copyng style, emotion and cancer: Towards and integrative model. Cancer Surv 1987; 6: 545-567. 13. Kune GA, Kune S, Watson LF, Bahnson CB. Personality as a risk factor in largue bowel cancer. Psychol Med 1991; 21: 29-41. 14. Grossarth-Maticek R, Eysenck HJ. Personality, stress and disease: Description and validation of a new inventory. Psychol Reports 1990; 66: 355-373. 15. Carver CS. Optimist versus pessimisms predicts the quality of women's adjustment to early stage breast cancer. Cancer 1994; 73: 1213-1220. 16. Green J, Shellenberger R. The dynamics of health and wellness. A byopsychosocial Approach. En: Holt, Rinehart, Winston, editores. Filadelfia 1991: 235-249. 17. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effects of psychosocial treatment on survival of patients with metastasic breast cancer. Lancet 1989; 2: 888-892. 18. Barinaga M. Can psychotherapy delay cancer deaths?. Science 1989; 246: 448-449. 19. Greer S, Morris T, Petfingale KW. Psychological response to breast cancer and 15 year outcome. Lancet 1990; 335: 49-50. 20. Fawzy FL, Fawzy NW, Hyun A. Malignant melanoma: Effect of an early structured psychiatric intervention, copyng, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993; 50: 681-689. 21. Ratcliffe MA, Dawson AA, Walker LG. Eysenck personality inventory 2-scores in patients with Hodkin's disease and non Hodgkin's lymphoma. Psycho-Oncology 1995; 4: 39-45. 22. Butow P, Coates A, Dunn S. Psychosocial predictors of survival in metastasic melanoma. J Clin Oncol 1999; 17: 2256-2260. 23. Butow P, Coates A, Dunn S. Psychosocial predictors of survival: metastasic breast cancer. Ann Oncol 2000; 11: 469-474. 24. Edelman S, Lemon J, Bell DR, Kidman AD. Effects of group CBT on the survival time of patients with metastasic breast cancer. Psycho-Oncology 1999; 8: 474-481. 25. Bayes R. Influencia de los factores psicológicos en la longitud de vida de los enfermos oncológicos. En: Martínez Roca editor. Psicología Oncológica. Barcelona, 1990: 182-184.
|